20/20 Capital Management »

Aurinia Pharmaceuticals shares owned by 20/20 Capital Management

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by 20/20 Capital Management from 13F filings

Historical chart of 20/20 Capital Management investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by 20/20 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by 20/20 Capital Management

Quarter filed Position value Share count Share price at filing
2021-06-30 $171k 13k 12.98

More positions owned by 20/20 Capital Management

Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Specialized Funds Div App Etf (VIG)
Proshares Tr S&p 500 Dv Arist (NOBL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Blackrock Science & Technolo SHS (BST)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
J P Morgan Exchange-traded F Ultra Shrt Inc (JPST)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vaneck Vectors Etf Tr Pharmaceutical (PPH)
J P Morgan Exchange-traded F Intl Bd Opp Etf (JPIB)
Wisdomtree Tr Emer Mkt High Fd (DEM)
Apple (AAPL)

View all positions for 20/20 Capital Management

Top funds holding Aurinia Pharmaceuticals

Armistice Capital
BlackRock
NEA Management Company
Goldman Sachs Group
Nuveen Asset Management
Tang Capital Management
Geode Capital Management
Vanguard Group
Morgan Stanley
Rock Springs Capital Management
Susquehanna International
Northern Trust
Citigroup
Citadel Advisors
683 Capital Management

View all funds holding Aurinia Pharmaceuticals